Anagnostics Boosts Sales Force
News Feb 05, 2013
Karl Winkler (48) is another sales professional checking in at Anagnostics Bioanalysis GmbH (St. Valentin/NÖ).
Karl holds a sales diploma and worked for Heinen & Loewenstein - a medtech company - and for Messer Medical Austria.
In both positions he was responsible for the build-up of sales infrastructure and sales in Austria and abroad.
Karl Winkler worked already 20 years in sales and sales management, 11 years thereof in the medical field.
Karl’s field of excellence is drugs of abuse analytics. For the beginning he will focus on sales of drugs of abuse screening tests in German speaking countries (Germany, Austria, Switzerland).
Karl Winkler: “Anagnostics is a dynamic enterprise, which is now in the phase of market expansion. Our proprietary hybcell technology promises huge market potential and I am eager to contribute to the success of the company.”
Anagnostics Bioanalysis offers its innovative multiplexed diagnostics technology named hybcell technology in three areas: drugs of abuse screening for drug therapy, in the field of personalized medicine (companion diagnostics) and for integrated sepsis diagnostics.
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE
Fabric Genomics Partners to Improve Pediatric CareNews
Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.READ MORE
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until NowNews
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.READ MORE